Latest news
Takeda Targets High-Need Psoriasis Niche With New Phase 3b Zasocitinib Study - TipRanksTipRanks · Fri, 07 Aug 2026 19:54:45 GMTAbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial - TipRanksTipRanks · Fri, 07 Aug 2026 17:02:38 GMTBayer Probes Sevabertinib–Metformin Combo In New Phase 1 Study - TipRanksTipRanks · Fri, 07 Aug 2026 16:38:28 GMTLiquidia Expands LIQ861 Into Raynaud’s: What the New RE-WARM Study Means for Investors - TipRanksTipRanks · Fri, 07 Aug 2026 16:38:27 GMTTakeda’s LIVTENCITY CMV Study in Japan: What Investors Should Watch - TipRanksTipRanks · Fri, 07 Aug 2026 16:38:26 GMTQuantum Machines Highlights Advanced Quantum Error Protection Research - TipRanksTipRanks · Fri, 07 Aug 2026 15:11:56 GMTCustomer Case Study Underscores Traction for Procurement Sciences’ Awarded AI Platform - TipRanksTipRanks · Fri, 07 Aug 2026 03:45:08 GMTMirum sinks after FDA recommends conducing Phase 3 study - TipRanksTipRanks · Fri, 07 Aug 2026 03:07:25 GMT